Atlas Trials

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

Clinical trial NCT00479219 · COMPLETED

Trial details

NCT number
NCT00479219
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2007-05-01
Primary completion
2007-10-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.